Childhood discoid lupus: check the ANA and watch closely in the first year

Design

Multicentre retrospective cohort, 17 paediatric sites

Population

Children with skin-limited discoid lupus erythematosus

Primary outcome

Time to diagnosis of SLE (ACR criteria)

Effect

14.4% at 1 year (95% CI 9.6 to 18.9); ANA-positive HR 3.71

A retrospective cohort from 17 paediatric centres followed children with discoid lupus confined to the skin. Within one year, 14.4% met classification criteria for systemic lupus erythematosus.

A positive antinuclear antibody at baseline was the strongest predictor, with nearly four times the hazard of progression. Older age at onset, antiphospholipid antibodies and cytopenias also predicted progression. Encouragingly, most children who progressed had mild systemic disease — mucocutaneous features and laboratory abnormalities — and only about 3% developed other organ involvement.

The study was published in June; it is included because it gives a clear, low-cost action for a rare condition that dermatologists usually manage alone. The design was retrospective with missing data, and it does not show that earlier treatment prevents progression.

• Check ANA, full blood count, urinalysis and antiphospholipid antibodies when a child presents with discoid lupus.
• Review ANA-positive children more often in the first year, with blood count and urine at each visit.
• Ask at each visit about joint pain, mouth ulcers, fevers and fatigue that could signal systemic disease.
• Involve paediatric rheumatology early when ANA is positive or cytopenias are found.
• Reassure families that severe organ disease after progression was uncommon in this cohort.

Why it matters

One in seven children progressed within a year, and a test most clinics already run identifies who they are likely to be.

Don't overread it

This retrospective cohort identifies risk factors but does not show that closer monitoring or early treatment changes outcomes.

The statistics, in plain English

The one-year progression estimate of 14.4% has a 95% confidence interval of 9.6% to 18.9%. A hazard ratio of 3.71 for a positive ANA means those children progressed at nearly four times the rate of ANA-negative children over follow-up.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.